Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Controlled Trial to Evaluate the Role of Oral Azithromycin in the Treatment of Symptomatic Meibomian Gland Disease and Its Effect on the Ocular Surface Microbiome

NCT03953118 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT03953118
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03953118 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Controlled Trial to Evaluate the Role of Oral Azithromycin in the Treatment of Symptomatic Meibomian Gland Disease and Its Effect on the Ocular Surface Microbiome
Lead sponsor
University of California, San Francisco
Phase
Phase 4
Overall status
Terminated
Start date
September 1, 2019
Completion date
July 1, 2021
Enrollment
2 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depression, anxiety, dry eye, neuropathic eye pain, ocular microbiome